Literature DB >> 29722652

Live to SABR Another Day?

Phuoc T Tran1, Felix Feng2, Piet Ost3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29722652      PMCID： PMC6330048          DOI： 10.1016/j.ijrobp.2018.01.104

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  6 in total

Review 1.  Radiotherapy as metastasis-directed therapy for oligometastatic prostate cancer.

Authors:  Elise De Bleser; Phuoc T Tran; Piet Ost
Journal:  Curr Opin Urol       Date:  2017-11       Impact factor: 2.309

2.  Intermittent androgen suppression for rising PSA level after radiotherapy.

Authors:  Juanita M Crook; Christopher J O'Callaghan; Graeme Duncan; David P Dearnaley; Celestia S Higano; Eric M Horwitz; Eliot Frymire; Shawn Malone; Joseph Chin; Abdenour Nabid; Padraig Warde; Thomas Corbett; Steve Angyalfi; S Larry Goldenberg; Mary K Gospodarowicz; Fred Saad; John P Logue; Emma Hall; Paul F Schellhammer; Keyue Ding; Laurence Klotz
Journal:  N Engl J Med       Date:  2012-09-06       Impact factor: 91.245

3.  The FinnProstate Study VII: intermittent versus continuous androgen deprivation in patients with advanced prostate cancer.

Authors:  Arto J Salonen; Kimmo Taari; Martti Ala-Opas; Jouko Viitanen; Seppo Lundstedt; Teuvo L J Tammela
Journal:  J Urol       Date:  2012-04-11       Impact factor: 7.450

4.  Adjuvant radiotherapy after salvage lymph node dissection because of nodal relapse of prostate cancer versus salvage lymph node dissection only.

Authors:  Hans Christian Rischke; Wolfgang Schultze-Seemann; Gesche Wieser; Malte Krönig; Vanessa Drendel; Petra Stegmaier; Tobias Krauss; Karl Henne; Natalia Volegova-Neher; Daniel Schlager; Simon Kirste; Anca-Ligia Grosu; Cordula Annette Jilg
Journal:  Strahlenther Onkol       Date:  2014-10-18       Impact factor: 3.621

5.  Intermittent versus continuous androgen deprivation in prostate cancer.

Authors:  Maha Hussain; Catherine M Tangen; Donna L Berry; Celestia S Higano; E David Crawford; Glenn Liu; George Wilding; Stephen Prescott; Subramanian Kanaga Sundaram; Eric Jay Small; Nancy Ann Dawson; Bryan J Donnelly; Peter M Venner; Ulka N Vaishampayan; Paul F Schellhammer; David I Quinn; Derek Raghavan; Benjamin Ely; Carol M Moinpour; Nicholas J Vogelzang; Ian M Thompson
Journal:  N Engl J Med       Date:  2013-04-04       Impact factor: 91.245

6.  A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).

Authors:  Noura Radwan; Ryan Phillips; Ashley Ross; Steven P Rowe; Michael A Gorin; Emmanuel S Antonarakis; Curtiland Deville; Stephen Greco; Samuel Denmeade; Channing Paller; Daniel Y Song; Maximilian Diehn; Hao Wang; Michael Carducci; Kenneth J Pienta; Martin G Pomper; Theodore L DeWeese; Adam Dicker; Mario Eisenberger; Phuoc T Tran
Journal:  BMC Cancer       Date:  2017-06-29       Impact factor: 4.430
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.